Study on Topical Infliximab for Autoimmune Dry Eye Disease in Sjögren's Syndrome
A clinical trial is underway to evaluate the safety and efficacy of topical infliximab for treating severe dry eye in Sjögren's syndrome.
Indication
Clinical and regulatory intelligence for Autoimmune Dry Eye Disease with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.